| Monroe Hospital | |
| 4011 S Monroe Medical Park Blvd, Bloomington, Indiana 47403 | |
| (812) 825-1111 | |
| Name | Monroe Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 4011 S Monroe Medical Park Blvd, Bloomington, Indiana |
| Ownership | Proprietary |
| Emergency Services | Yes |
| Medicare ID (CCN) | 150183 |
| NPI Number | 1164806444 |
| Organization Name | MONROE HOSOITAL |
| Address | 4011 Monroe Medical Park, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 812-825-1111 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| NPI Number | 1184305526 |
| Organization Name | IRVING RADIOLOGY, INC |
| Address | 4011 S Monroe Medical Park Blvd, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 239-309-0602 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| NPI Number | 1588863534 |
| Organization Name | MONROE PHYSICIANS GROUP |
| Address | 4011 S Tiwari Blvd, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 812-825-1111 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| NPI Number | 1740686443 |
| Organization Name | PRIME HEALTHCARE SERVICES - MONROE LLC |
| Doing Business As | MONROE HOSPITAL |
| Address | 4011 S Monroe Med Park Blvd, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 812-825-1111 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| NPI Number | 1831123942 |
| Organization Name | MONROE HOSPITAL, LLC |
| Address | 4011 S Monroe Medical Park Blvd, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 812-825-1111 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| NPI Number | 1952338444 |
| Organization Name | MONROE HOSPITAL, LLC |
| Address | 4011 S Tiwari Blvd, Bloomington, IN 47403 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 812-825-5777 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Georgia has received $63.9 million in Ryan White Program grants to fund treatment and other services for people living with HIV, the Atlanta Journal-Constitution reports.
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
› Verified 2 days ago
Indiana University Health Bloomington Hospital Acute Care Hospital Location: 601 W Second St, Bloomington, Indiana 47403 Phone: (812) 353-9555 | |
Monroe Hospital Acute Care Hospital Location: 4011 S Monroe Medical Park Blvd, Bloomington, Indiana 47403 Phone: (812) 825-1111 | |
Bloomington Meadows Hospital Psychiatric Hospital Location: 3600 N Prow Rd, Bloomington, Indiana 47404 Phone: (812) 331-8000 |